A comprehensive review of adverse events to drugs used in COVID‐19 patients: Recent clinical evidence-Reference-Cited by-同舟云学术

A comprehensive review of adverse events to drugs used in COVID‐19 patients: Recent clinical evidence

Published:2022-02-27 Issue:7 Volume:52 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Ferreira‐da‐Silva Renato¹²³^ORCID,Ribeiro‐Vaz Inês¹²³^ORCID,Morato Manuela⁴^ORCID,Junqueira Polónia Jorge¹³⁵^ORCID

Affiliation:

1. Porto Pharmacovigilance Centre, INFARMED, I.P University of Porto Porto Portugal

2. Department of Community Medicine, Health Information and Decision University of Porto Porto Portugal

3. CINTESIS – Center for Health Technology and Services Research Porto Portugal

4. LAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences University of Porto Porto Portugal

5. Department of Medicine University of Porto Porto Portugal

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13763

Reference195 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. World Health Organization. WHO Coronavirus Disease (COVID‐19) Dashboard. Accessed November 16 2021.https://covid19.who.int/?gclid=CjwKCAiA8Jf‐BRB‐EiwAWDtEGrzwwPU_OzZBe01nimHAyQk_JkPo65wlzBS27YLZRzzNZECD5CbzBBoCZM0QAvD_BwE

3. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

4. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial;Journal of Vascular Surgery;2024-09

2. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial;Journal of Vascular Surgery;2023-10

3. Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research;The Journal of Clinical Pharmacology;2023-01-09

4. Does the use of cysteine-rich whey protein supplements (Inmunocal®) improve the health well-being of COVID-19 patients? A qualitative study;Electronic Journal of General Medicine;2023-01-01

5. The role of platelets, neutrophils and endothelium in COVID-19 infection;Expert Review of Hematology;2022-08-03